News & Events

"This agreement supports our long-standing commitment to protect health care workers from injury and infection and to help them deliver the highest-quality patient care," said Gary Cohen, Executive Vice President, Becton Dickinson. "Med-Design's versatile, cost-effective design solutions are applicable to a broad range of products. This is the kind of design flexibility that we look for when we consider how to best meet the needs of doctors, nurses, hospitals and other health care facilities."

Cohen emphasized that the Med-Design partnership is well aligned with the goals of BD Advanced Protection Technologies (BDAPT), the unit that coordinates the development, production and marketing of the Company's extensive line of advanced protection products and services.

James M. Donegan, Chairman and Chief Executive Officer of The Med-Design Corporation, said: "Becton Dickinson is exactly the kind of partner a company like ours looks for, because it understands the value of our designs and is committed to putting them in the hands of doctors and nurses. We've worked hard to make the best retractable needle technology available, and BD - with over ten years of dedication to advanced protection products - is the ideal partner to develop and bring our designs to market."

Becton Dickinson pioneered the development of advanced protection "sharps" devices designed to protect health care workers against accidental sharps injuries, introducing its first advanced protection product in 1989. In the past five years the Company has invested over $100 million in advanced protection products and services, including extensive clinical training and education programs. The company holds 75 patents in this area and today sells over 200 advanced protection products for injection, blood collection, infusion therapy, surgery, and disposal.

The Med-Design Corporation holds various U.S. and international patents on medical devices with advanced protection features that are designed to reduce the incidence of accidental sharps injuries. The company's products incorporate a proprietary retraction technology developed at its Ventura, California headquarters, R&D and pilot-manufacturing facility.